Proteomic analysis reveals warburg effect and anomalous metabolism of glutamine in pancreatic cancer cells

Journal of Proteome Research

Volumn 11, Issue 2, 2012, Pages 554-563

  Zhou, Weidong ^a   Capello, Michela ^b,c   Fredolini, Claudia ^a,b,c   Racanicchi, Leda ^d   Piemonti, Lorenzo ^d   Liotta, Lance A ^a   Novelli, Francesco ^b,c   Petricoin, Emanuel F ^a  

^a GEORGE MASON UNIVERSITY   (United States)

^b MOLINETTE HOSPITAL   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

glutamine; mass spectrometry; metabolism; pancreatic ductal adenocarcinoma; proteomics; Warburg effect

Indexed keywords

GLUTAMINE;

AMINO ACID SYNTHESIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL ADHESION; CELL PROLIFERATION; CELL TRANSPORT; CONTROLLED STUDY; CYTOSKELETON; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; METABOLISM; NUCLEOTIDE METABOLISM; PANCREAS ADENOCARCINOMA; PANCREAS DUCT; PANCREAS DUCT ADENOCARCINOMA; PRIORITY JOURNAL; PROTEOMICS; TANDEM MASS SPECTROMETRY; WARBURG EFFECT;

CARCINOMA, PANCREATIC DUCTAL; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CHROMATOGRAPHY, LIQUID; DOWN-REGULATION; GLUTAMINE; HUMANS; METABOLIC NETWORKS AND PATHWAYS; PANCREATIC NEOPLASMS; PROTEOME; PROTEOMICS; TANDEM MASS SPECTROMETRY; UP-REGULATION;

EID: 84856655854     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr2009274     Document Type: Article

References (45)

1. Stryer, L. Biochemistry; W. H. Freeman and Company: NewYork, 1995.
2. Warburg, O. On respiratory impairment in cancer cells Science 1956, 124 (3215) 269-270
3. Vander Heiden, M. G.; Cantley, L. C.; Thompson, C. B. Understanding the Warburg effect: the metabolic requirements of cell proliferation Science 2009, 324 (5930) 1029-1033
4. Levine, A. J.; Puzio-Kuter, A. M. The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes Science 2010, 330 (6009) 1340-1344
5. Koppenol, W. H.; Bounds, P. L.; Dang, C. V. Otto Warburg's contributions to current concepts of cancer metabolism Nat. Rev. Cancer 2011, 11 (5) 325-337
6. DeBerardinis, R. J.; Mancuso, A.; Daikhin, E.; Nissim, I.; Yudkoff, M.; Wehrli, S.; Thompson, C. B. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis Proc. Natl. Acad. Sci. U.S.A. 2007, 104 (49) 19345-19350
7. Erickson, J. W.; Cerione, R. A. Glutaminase: a hot spot for regulation of cancer cell metabolism? Oncotarget 2010, 1 (8) 734-740
8. DeBerardinis, R. J.; Cheng, T. Q's next: The diverse functions of glutamine in metabolism, cell biology and cancer Oncogene 2010, 29 (3) 313-324
9. Ghaneh, P.; Costello, E.; Neoptolemos, J. P. Biology and management of pancreatic cancer Gut 2007, 56 (8) 1134-1152
10. Omura, N.; Goggins, M. Epigenetics and epigenetic alterations in pancreatic cancer Int. J. Clin. Exp. Pathol. 2009, 2 (4) 310-326
11. Chen, R.; Pan, S.; Brentnall, T. A.; Aebersold, R. Proteomic profiling of pancreatic cancer for biomarker discovery Mol. Cell. Proteomics 2005, 4 (4) 523-533
12. Aspinall-O'Dea, M.; Costello, E. The pancreatic cancer proteome - recent advances and future promise Proteomics Clin. Appl. 2007, 1 (9) 1066-1079
13. Chen, R.; Pan, S.; Aebersold, R.; Brentnall, T. A. Proteomics studies of pancreatic cancer Proteomics Clin. Appl. 2007, 1 (12) 1582-1591
14. Tonack, S.; Aspinall-O'Dea, M.; Neoptolemos, J. P.; Costello, E. Pancreatic cancer: proteomic approaches to a challenging disease Pancreatology 2009, 9 (5) 567-576
15. Schoumacher, R. A.; Ram, J.; Iannuzzi, M. C.; Bradbury, N. A.; Wallace, R. W.; Hon, C. T.; Kelly, D. R.; Schmid, S. M.; Gelder, F. B.; Rado, T. A. A cystic fibrosis pancreatic adenocarcinoma cell line Proc. Natl. Acad. Sci. U.S.A. 1990, 87 (10) 4012-4016
16. Zhou, W.; Capello, M.; Fredolini, C.; Piemonti, L.; Liotta, L.; Novelli, F.; Petricoin, E. Proteomic analysis of pancreatic ductal adenocarcinoma cells reveals metabolic alterations J. Proteome Res. 2011, 10 (4) 1944-1952
17. Lieber, M.; Mazzetta, J.; Nelson-Rees, W.; Kaplan, M.; Todaro, G. Establishment of a continuous tumor-cell line (panc-1) from a human carcinoma of the exocrine pancreas Int. J. Cancer 1975, 15 (5) 741-747
18. Klein, T.; Heremans, Y.; Heimberg, H.; Pipeleers, D.; Madsen, O. D.; Serup, P.; Heller, R. S. Investigation and characterization of the duct cell-enriching process during serum-free suspension and monolayer culture using the human exocrine pancreas fraction Pancreas 2009, 38 (1) 36-48
19. Elias, J. E.; Gygi, S. P. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry Nat. Methods 2007, 4 (3) 207-214
20. Snyder, L. R.; Kirkland, J. J.; Dolan, J. W. Introduction to modern liquid chromatography; John Wiley & Sons, Inc.: Hoboken, NJ, 2010.
21. Liu, H.; Sadygov, R.; Yates, J. R., III A model for random sampling and estimation of relative protein abundance in shotgun proteomics Anal. Chem. 2004, 76 (14) 4193-4201
22. Ishihama, Y.; Oda, Y.; Tabata, T.; Sato, T.; Nagasu, T.; Rappsilber, J.; Mann, M. Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein Mol. Cell. Proteomics 2005, 4 (9) 1265-1272
23. Haimoto, H.; Takahashi, Y.; Koshikawa, T.; Nagura, H.; Kato, K. Immunohistochemical localization of gamma-enolase in normal human tissues other than nervous and neuroendocrine tissues Lab Invest. 1985, 52 (3) 257-263
24. Wise, D. R.; Thompson, C. B. Glutamine addiction: a new therapeutic target in cancer Trends Biochem. Sci. 2010, 35 (8) 427-433
25. Kizaki, H.; Williams, J. C.; Morris, H. P.; Weber, G. Increased cytidine 5′-triphosphate synthetase activity in rat and human tumors Cancer Res. 1980, 40 (11) 3921-3927
26. Ahluwalia, G. S.; Grem, J. L.; Hao, Z.; Cooney, D. A. Metabolism and action of amino acid analog anti-cancer agents Pharmacol. Ther. 1990, 46 (2) 243-271
27. Cerini, C.; Kerjan, P.; Astier, M.; Gratecos, D.; Mirande, M.; Semeriva, M. A component of the multisynthetase complex is a multifunctional aminoacyl-tRNA synthetase EMBO J. 1991, 10 (13) 4267-4277
28. Orlandi, A.; Ferlosio, A.; Ciucci, A.; Francesconi, A.; Lifschitz-Mercer, B.; Gabbiani, G.; Spagnoli, L. G.; Czernobilsky, B. Cellular retinol binding protein-1 expression in endometrial hyperplasia and carcinoma: diagnostic and possible therapeutic implications Mod. Pathol. 2006, 19 (6) 797-803
29. Zhang, P.; Zhang, C.; Wang, X.; Liu, F.; Sung, C. J.; Quddus, M. R.; Lawrence, W. D. The expression of selenium-binding protein 1 is decreased in uterine leiomyoma Diagn. Pathol. 2010, 5, 80
30. Raucci, R.; Colonna, G.; Guerriero, E.; Capone, F.; Accardo, M.; Castello, G.; Costantini, S. Structural and functional studies of the human selenium binding protein-1 and its involvement in hepatocellular carcinoma Biochim. Biophys. Acta 2011, 1814 (4) 513-522
31. Allison, A. C. Lysosomes in cancer cells J. Clin. Pathol. Suppl. (R. Coll. Pathol.) 1974, 7, 43-50
32. Fehrenbacher, N.; Jäättelä, M. Lysosomes as targets for cancer therapy Cancer Res. 2005, 65 (8) 2993-2995
33. Kroemer, G.; Jäättelä, M. Lysosomes and autophagy in cell death control Nat. Rev. Cancer 2005, 5 (11) 886-897
34. Rochefort, H. Cathepsin D in breast cancer: a tissue marker associated with metastasis Eur. J. Cancer 1992, 28A, 1780-1783
35. Motojima, K.; Urano, T.; Nagata, Y.; Shiku, H.; Tsurifune, T.; Kanematsu, T. Detection of point mutations in the Kirsten-ras oncogene provides evidence for the multicentricity of pancreatic carcinoma Ann. Surg. 1993, 217 (2) 138-143
36. Arany, Z.; Huang, L. E.; Eckner, R.; Bhattacharya, S.; Jiang, C.; Goldberg, M. A.; Bunn, H. F.; Livingston, D. M. An essential role for p300/CBP in the cellular response to hypoxia Proc. Natl. Acad. Sci. U.S.A. 1996, 93 (23) 12969-12973
37. Jaakkola, P.; Mole, D. R.; Tian, Y. M.; Wilson, M. I.; Gielbert, J.; Gaskell, S. J.; Kriegsheim, Av.; Hebestreit, H. F.; Mukherji, M.; Schofield, C. J.; Maxwell, P. H.; Pugh, C. W.; Ratcliffe, P. J. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation Science 2001, 292 (5516) 468-472
38. Ozawa, K.; Kuwabara, K.; Tamatani, M.; Takatsuji, K.; Tsukamoto, Y.; Kaneda, S.; Yanagi, H.; Stern, D. M.; Eguchi, Y.; Tsujimoto, Y.; Ogawa, S.; Tohyama, M. 150-kDa oxygen-regulated protein (ORP150) suppresses hypoxia-induced apoptotic cell death J. Biol. Chem. 1999, 274 (10) 6397-6404
39. Fodale, V.; Pierobon, M.; Liotta, L.; Petricoin, E. Mechanism of cell adaptation: when and how do cancer cells develop chemoresistance? Cancer J. 2011, 17 (2) 89-95
40. Harrison, L. B.; Chadha, M.; Hill, R. J.; Hu, K.; Shasha, D. Impact of tumor hypoxia and anemia on radiation therapy outcomes Oncologist 2002, 7 (6) 492-508
41. Pelicano, H.; Martin, D. S.; Xu, R. H.; Huang, P. Glycolysis inhibition for anticancer treatment Oncogene 2006, 25 (34) 4633-4646
42. Shelton, L. M.; Huysentruyt, L. C.; Mukherjee, P.; Seyfried, T. N. Calorie restriction as an anti-invasive therapy for malignant brain cancer in the VM mouse ASN Neuro. 2010, 2 (3) e00038
43. Domon, B.; Aebersold, R. Mass spectrometry and protein analysis Science 2006, 312 (5771) 212-217
44. Cravatt, B. F.; Simon, G. M.; Yates, J. R., III The biological impact of mass-spectrometry-based proteomics Nature 2007, 450 (7172) 991-1000
45. Nilsson, T.; Mann, M.; Aebersold, R.; Yates, J. R., III; Bairoch, A.; Bergeron, J. J. Mass spectrometry in high-throughput proteomics: ready for the big time Nat. Methods 2010, 7 (9) 681-685